SMA News Today Home | SMA News Today
WEBSep 18, 2024 · The use of ultrasound to guide the administration of Spinraza (nusinersen) injection into the spinal canals of adults with spinal muscle atrophy (SMA) significantly reduced the number of needle redirections compared with a standard, landmark-based approach, according to a clinical trial. Among patients with …
Spinal Muscular Atrophy: Nutrition and Supplementation
WEBThe nutritional management of patients with progressive neuromuscular diseases like Spinal Muscular Atrophy (SMA) is complex and is achieved optimally with an individualized approach from a multidisciplinary care team. 1,2 Patients with SMA need nutritional monitoring at least annually with assessment of caloric intake and standard ...
FDA Approves Evrysdi, First Oral Treatment for All SMA Types
WEBAug 7, 2020 · The U.S. Food and Drug Administration (FDA) has approved Evrysdi — formerly known as risdiplam — as the first oral and at-home treatment for adults, children, and infants 2 months of age and older with all types of spinal muscular atrophy (SMA). With this action, Evrysdi — marketed by Genentech, a subsidiary of Roche — is now the third ...
SMN2 Copy Number and Rare Variant Influence SMA Severity
WEBMay 24, 2021 · by Marta Figueiredo, PhD May 24, 2021. The number of copies of the “backup” SMN2 gene and a rare genetic variant in this gene influence disease severity in people with spinal muscular atrophy (SMA), according to data from more than 2,000 people involved in a free SMA genetic testing program. Launched in 2018 by Biogen and Invitae ...
SMA Gene Therapy Zolgensma 'Saved All of Our Lives': A Family's …
WEBJun 14, 2019 · Zolgensma ‘Saved All of Our Lives’: A Family’s Journey Through Gene Therapy. by Marisa Wexler, MS June 14, 2019. Malachi was one of the first babies treated with Zolgensma. Tina and Torence Anderson’s sixth and youngest child, Malachi, came into the world on July 31, 2015. “When he was born, he was normal,” Tina said in a phone ...
Spinal muscular atrophy diagnosis and testing - SMA News Today
WEBJan 20, 2023 · Genetic tests for SMA. The gold standard for a spinal muscular atrophy diagnosis is genetic testing to identify whether a potential patient has the disease-causing mutations. A number of technologies may be used for this type of testing, ranging from techniques that look for common mutations in specific genes to …
Spinal Muscular Atrophy: Cardiac Disease – HCP SMA News Today
WEBSpinal Muscular Atrophy (SMA) is an inherited neurodegenerative disease, 1 but it is increasingly clear that the pathology of SMA extends beyond ventral horn spinal cord neurons and includes the heart among other organs. 2 In patients with SMA, tissue levels of SMN1 protein are reduced in heart tissues, 3 and numerous mouse models of SMA exhibit cardiac developmental abnormalities which ...
Physical Therapy for SMA – HCP SMA News Today
WEBPhysical Therapy for SMA. According to the 2018 consensus report on the diagnosis and management of spinal muscular atrophy published by the SMA Care Group, physical therapy is an important part of the care of patients with SMA. 1 Indeed, regular sessions of physical therapy may influence the trajectory of disease progression.
SMA Type 1: Symptoms, Treatment, and More - SMA News Today
WEBFeb 2, 2023 · a lack of reflexes. In addition to impacting the muscles used to move the body around, SMA type 1 commonly affects muscles in the chest, throat, and mouth. This can lead to symptoms including: difficulty feeding, due to weakness in the muscles used for sucking, swallowing, and chewing. poor head control and involuntary tongue movements.
Spinal Muscular Atrophy (SMA) Types – SMA News Today
WEBFeb 2, 2023 · Spinal muscular atrophy, or SMA, is a genetic disorder that is divided into five main types based on the age at which symptoms first appear. These forms of SMA range from type 0, which occurs before birth, to type 4, in which symptoms do not start until adulthood. The more common types — 1, 2, and 3 — typically manifest in infancy, or in ...